4.7 Review

Challenges in drug delivery to tumors of the central nervous system: An overview of pharmacological and surgical considerations

Journal

ADVANCED DRUG DELIVERY REVIEWS
Volume 64, Issue 7, Pages 590-597

Publisher

ELSEVIER
DOI: 10.1016/j.addr.2012.01.004

Keywords

Convection-enhanced delivery; CED; Intrathecal; Intranasal; Glioma; Glioblastoma; Liposome; Chemotherapy

Funding

  1. NINDS NIH HHS [R21 NS065819] Funding Source: Medline

Ask authors/readers for more resources

The majority of newly diagnosed brain tumors are treated with surgery, radiation, and the chemotherapeutic temozolomide. Development of additional therapeutics to improve treatment outcomes is complicated by the blood-brain barrier (BBB), which acts to protect healthy tissue from chemical insults. The high pressure found within brain tumors adds a challenge to local delivery of therapy by limiting the distribution of bolus injections. Here we discuss various drug delivery strategies, including convection-enhanced delivery, intranasal delivery, and intrathecal delivery, as well as pharmacological strategies for improving therapeutic efficacy, such as blood-brain barrier disruption. (c) 2012 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available